氯西加酮|T27845|TargetMol
Losigamone
112856-44-7
112856-44-7
¥530
1mg
起订
¥1250
5mg
起订
¥1860
10mg
起订
上海 更新日期:2025-08-20
产品详情:
- 中文名称:
- 氯西加酮
- 英文名称:
- Losigamone
- CAS号:
- 112856-44-7
- 品牌:
- TargetMol
- 产地:
- 美国
- 保存条件:
- Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
- 纯度规格:
- 99.98%
- 产品类别:
- 抑制剂
- 货号:
- T27845
Product Introduction
Bioactivity
| 名称 | Losigamone |
| 描述 | Losigamone (AO-33) is an agonist of GABA receptor and can be used in studies about the treatment of partial seizures. |
| 体内活性 | Losigamone (AO-33) was tested in 52 healthy male volunteers in 4 placebo-controlled phase I studies. In the study 1 single dose of 100, 200, 300, 500, 700, and 1,000 mg losigamone was given as a fast-releasing capsule to 12 subjects. The pharmacokinetics of losigamone measured after administration of 100, 300, and 700 mg was linear. Clearance and t1/2 were about 350 ml/min and 4 h, respectively, the Cmax values of 0.7, 1.7, and 4.4 micrograms/ml were reached after 2.5 h. In study, 2,500 mg losigamone was given as a fast-release capsule for 6 days (t.i.d.) to 12 subjects. There was a small but statistically significant decrease for the AUC but no change in t1/2, Cmax, or tmax comparing single dose kinetics on days 1 and 8. There appeared to be no change in caffeine clearance on days 1 and 9. Study 2 was repeated in 20 volunteers with a film-coated tablet. Pharmacokinetic parameters appeared to be unaffected by this change in galenical formulation. In the study 4 daily doses of 400, 1,200, and 1,800 mg losigamone were given 28 days to 24 subjects. The kinetics of caffeine and antipyrine were compared on days 1 and 29. With the exception of t1/2 for antipyrine in the 400 mg group there was no statistically significant change in pharmacokinetic parameters. Generally, losigamone was well tolerated and no serious adverse side effects occurred. In some subjects, a reversible increase in transaminases was observed.[1] |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 关键字 | Losigamone | GABAReceptor | GABAR | GABA Receptor | ADD137022 |
| 相关产品 | p-Hydroxybenzaldehyde | Penicillin G sodium salt | Lidocaine hydrochloride | Valproic Acid | Lidocaine | Urethane | Procaine | L-Aspartic aicd sodium | Dihydromyricetin | (-)-α-Pinene | Baicalin | Phenytoin sodium |
| 相关库 | 经典已知活性库 | 已知活性化合物库 | 神经递质受体化合物库 | 神经信号分子库 | 离子通道库 | 膜蛋白靶向化合物库 | 疼痛相关化合物库 |
氯西加酮|||AO-33|||AO33|||AO 33|||ADD137022;Losigamone|||ADD-137022|||ADD 137022|TargetMol
公司简介
TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。
| 成立日期 | (13年) |
| 注册资本 | 589.8595万人民币 |
| 员工人数 | 100-500人 |
| 年营业额 | ¥ 1亿以上 |
| 经营模式 | 贸易,工厂,试剂,定制,服务 |
| 主营行业 | 中间体,天然产物,生物化工,化学试剂,生物技术服务 |
氯西加酮相关厂家报价
-
- 培西加南
- 浙江杰坤生物科技有限公司 VIP
- 2025-11-10
- 询价
-
- 培西加南
- 杭州固拓生物科技有限公司 VIP
- 2025-11-12
- 询价
-
- 培西加南;147664-63-9
- 湖北摩科生物科技有限公司 VIP
- 2025-11-05
- 询价
内容声明
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。
商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的